Curis Lifesciences (NSE:CURIS) Cash Flow for Dividends: ₹0.0 Mil (TTM As of Mar. 2026)


NSE:CURIS Curis Lifesciences Ltd NSE:CURIS
19 GF Score
Price ₹100.70
! 2 Warning Signs
View Full Analysis

What is Curis Lifesciences Cash Flow for Dividends?

Curis Lifesciences NSE:CURIS 19 Cash Flow for Dividends is ₹0.0 Mil as of Mar. 2026. GuruFocus rates NSE:CURIS with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

Curis Lifesciences's cash flow for dividends for the six months ended in Mar. 2026 was ₹0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Curis Lifesciences Cash Flow for Dividends Related Terms

Curis Lifesciences Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Curis Lifesciences's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curis Lifesciences Cash Flow for Dividends Chart

Curis Lifesciences Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
0.00 0.00 0.00 0.00

Curis Lifesciences Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends 0.00 0.00 0.00 0.00
NSE:CURIS
19GF Score
Curis Lifesciences Ltd NSE:CURIS
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Lifesciences Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0.0 Mil mean?
Curis Lifesciences (NSE:CURIS) has a Cash Flow for Dividends of ₹0.0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Curis Lifesciences and its competitors.
Is Curis Lifesciences' Cash Flow for Dividends too high?
Curis Lifesciences' current Cash Flow for Dividends is ₹0.0 Mil. Overall, Curis Lifesciences has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' Cash Flow for Dividends compare to ZTS and UTHR?
Curis Lifesciences' Cash Flow for Dividends of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Curis Lifesciences and its competitors. Curis Lifesciences's current Cash Flow for Dividends is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current Cash Flow for Dividends of ₹0.0 Mil. The current Cash Flow for Dividends is ₹0.0 Mil. Curis Lifesciences' overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current Cash Flow for Dividends is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curis Lifesciences Business Description

Address PF-23, GIDC Sanand - II, Industrial Acme Pharma, Opposite Teva Pharma, Sanand, Ahmedabad, GJ, IND, 382110
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
19GF Score

Get the complete analysis for NSE:CURIS

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹100.70
Price